中国≥65岁老年人中结核分枝杆菌抗原皮肤试验与干扰素γ释放试验的一致性
基于一项随机对照试验的基线调查,采用横断面设计,在50-70岁农村居民中平行开展结核分枝杆菌抗原皮肤试验(TBST)与干扰素γ释放试验(IGRA)。共纳入21 219名同时具备两项结果的参与者,总体一致率为89.4%(95% CI 89.0-89.8%),kappa系数0.61(95% CI 0.60-0.62);在≥65岁人群中一致率为86.5%(95% CI 85.6-87.4%),kappa系数0.55(95% CI 0.52-0.58)。
要点
- ≥65岁人群TBST与IGRA一致率86.5%(95% CI 85.6-87.4%),kappa系数0.55(95% CI 0.52-0.58)。
- 总体人群一致率89.4%(95% CI 89.0-89.8%),kappa系数0.61(95% CI 0.60-0.62)。
- IGRA结果不确定者中21.2%(35/165)TBST阳性,其中9人≥65岁。
核心结论
- 在≥65岁人群中TBST与IGRA呈现一致性,提示TBST有潜力用于超出中国说明书年龄范围的老年人。
- 各试验各自的诊断性能将在未来获得结核发病纵向数据后进行分析。
研究设计与样本
- 基于一项探索结核预防性治疗适宜方案的随机对照试验的基线调查,采用横断面研究设计。
- 在农村50-70岁居民中平行使用TBST和IGRA检测结核分枝杆菌感染。
- 共纳入21 219名同时具备TBST和IGRA结果的参与者。
主要发现
- TBST与IGRA总体一致率为89.4%(95% CI 89.0-89.8%),kappa系数0.61(95% CI 0.60-0.62)。
- 在≥65岁人群中,一致率为86.5%(95% CI 85.6-87.4%),kappa系数0.55(95% CI 0.52-0.58)。
- IGRA结果不确定的参与者中,21.2%(35/165)TBST阳性,其中9人年龄≥65岁。
临床怎么用
- 原文未据此给出推荐。
局限性
- 各试验各自的诊断性能需在未来获得结核发病纵向数据后进行分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the agreement of Mycobacterium tuberculosis (MTB) antigen-based skin test (TBST) with interferon-gamma release assay (IGRA) in the elderly individuals aged ≥65 years beyond instruction for use in China. METHODS: Based on the baseline survey of a randomized controlled trial with the objective of exploring suitable regimens for tuberculosis(TB) preventive treatment, MTB infection was tested using TBST and IGRA in parallel in rural residents aged 50-70 years using a cross-sectional study design. RESULTS: A total of 21 219 participants with both TBST and IGRA results were included in this analysis. The concordance between TBST and IGRA was 89.4% (95% CI, 89.0-89.8%) with a kappa coefficient of 0.61 (95% CI, 0.60-0.62). In those aged ≥65 years, the concordance was 86.5% (95% CI, 85.6-87.4%) with a kappa coefficient of 0.55 (95% CI, 0.52-0.58). 21.2% (35/165) of the participants with indeterminate IGRA results were TBST positive, and nine of them were aged ≥65 years. DISCUSSION: The consistent agreement between TBST and IGRA in individuals aged ≥65 years suggests that TBST has the potential to be used in the elderly with age beyond instruction for use in China. The respective diagnostic performance of each test will be analysed when the longitudinal data on incident TB is obtained in the future.
引用
- He Y, Shen L, Du J, et al. Agreement between Mycobacterium tuberculosis antigen-based skin test and interferon-gamma release assay in elderly individuals aged ≥65 years in China. Clin Microbiol Infect. 2024. PMID: 39454755. doi:10.1016/j.cmi.2024.10.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。